These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10381144)

  • 1. Substrate interactions in the short- and long-term regulation of renal glucose oxidation.
    Sugden MC; Holness MJ; Donald E; Lall H
    Metabolism; 1999 Jun; 48(6):707-15. PubMed ID: 10381144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective modification of pyruvate dehydrogenase kinase isoform expression in rat pancreatic islets elicited by starvation and activation of peroxisome proliferator-activated receptor-alpha: implications for glucose-stimulated insulin secretion.
    Sugden MC; Bulmer K; Augustine D; Holness MJ
    Diabetes; 2001 Dec; 50(12):2729-36. PubMed ID: 11723055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective modification of the pyruvate dehydrogenase kinase isoform profile in skeletal muscle in hyperthyroidism: implications for the regulatory impact of glucose on fatty acid oxidation.
    Sugden MC; Lall HS; Harris RA; Holness MJ
    J Endocrinol; 2000 Nov; 167(2):339-45. PubMed ID: 11054649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibre-type specific modification of the activity and regulation of skeletal muscle pyruvate dehydrogenase kinase (PDK) by prolonged starvation and refeeding is associated with targeted regulation of PDK isoenzyme 4 expression.
    Sugden MC; Kraus A; Harris RA; Holness MJ
    Biochem J; 2000 Mar; 346 Pt 3(Pt 3):651-7. PubMed ID: 10698691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone.
    Holness MJ; Bulmer K; Smith ND; Sugden MC
    Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.
    Sugden MC; Holness MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):151-65. PubMed ID: 12476789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of increased dietary lipid on the regulation of glucose uptake and oxidation by insulin in brown- and a range of white-adipose-tissue depots in vivo.
    Holness MJ; Sugden MC
    Int J Obes Relat Metab Disord; 1999 Jun; 23(6):629-38. PubMed ID: 10411237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fatty acids and ketones on the activity of pyruvate dehydrogenase in skeletal-muscle mitochondria.
    Ashour B; Hansford RG
    Biochem J; 1983 Sep; 214(3):725-36. PubMed ID: 6138029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of muscle pyruvate oxidation during late pregnancy.
    Sugden MC; Holness MJ
    FEBS Lett; 1993 Apr; 321(2-3):121-6. PubMed ID: 8477840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding.
    Sugden MC; Bulmer K; Gibbons GF; Holness MJ
    Arch Biochem Biophys; 2001 Nov; 395(2):246-52. PubMed ID: 11697863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine metabolism in livers and hearts of 48h-starved rats: the contribution of fat and carbohydrate to acylcarnitine formation.
    French TJ; Goode AW; Holness MJ; Sugden MC
    Biochem Int; 1985 Aug; 11(2):265-72. PubMed ID: 4052090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.
    Kantor PF; Lucien A; Kozak R; Lopaschuk GD
    Circ Res; 2000 Mar; 86(5):580-8. PubMed ID: 10720420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting and decreased B cell sensitivity: important role for fatty acid-induced inhibition of PDH activity.
    Zhou YP; Priestman DA; Randle PJ; Grill VE
    Am J Physiol; 1996 Jun; 270(6 Pt 1):E988-94. PubMed ID: 8764183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding.
    Holness MJ; Kraus A; Harris RA; Sugden MC
    Diabetes; 2000 May; 49(5):775-81. PubMed ID: 10905486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the long-term regulation of hepatic pyruvate dehydrogenase kinase.
    Sugden MC; Fryer LG; Orfali KA; Priestman DA; Donald E; Holness MJ
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):89-94. PubMed ID: 9405279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid switch of hepatic fatty acid metabolism from oxidation to esterification during diurnal feeding of meal-fed rats correlates with changes in the properties of acetyl-CoA carboxylase, but not of carnitine palmitoyltransferase I.
    Moir AM; Zammit VA
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):241-6. PubMed ID: 8097087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
    Sugden MC; Priestman DA; Orfali KA; Holness MJ
    Horm Metab Res; 1999 May; 31(5):300-6. PubMed ID: 10422724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-fatty acid cycle to inhibit glucose utilization and oxidation is not operative in fatty acid-cultured islets.
    Liu YQ; Tornheim K; Leahy JL
    Diabetes; 1999 Sep; 48(9):1747-53. PubMed ID: 10480604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms underlying the long-term impact of dietary fat to increase cardiac pyruvate dehydrogenase kinase: regulation by insulin, cyclic AMP and pyruvate.
    Sugden MC; Orfali KA; Fryer LG; Holness MJ; Priestman DA
    J Mol Cell Cardiol; 1997 Jul; 29(7):1867-75. PubMed ID: 9236140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice.
    Hopkins TA; Sugden MC; Holness MJ; Kozak R; Dyck JR; Lopaschuk GD
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H270-6. PubMed ID: 12663261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.